These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15984900)

  • 61. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
    Yoshimoto M; Ogawa K; Washiyama K; Shikano N; Mori H; Amano R; Kawai K
    Int J Cancer; 2008 Aug; 123(3):709-15. PubMed ID: 18498129
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals.
    Bombardieri E; Coliva A; Maccauro M; Seregni E; Orunesu E; Chiti A; Lucignani G
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):3-15. PubMed ID: 20168282
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation.
    Koumarianou E; Mikołajczak R; Pawlak D; Zikos X; Bouziotis P; Garnuszek P; Karczmarczyk U; Maurin M; Archimandritis SC
    Nucl Med Biol; 2009 Aug; 36(6):591-603. PubMed ID: 19647165
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.
    de Jong M; Breeman WA; Bakker WH; Kooij PP; Bernard BF; Hofland LJ; Visser TJ; Srinivasan A; Schmidt MA; Erion JL; Bugaj JE; Mäcke HR; Krenning EP
    Cancer Res; 1998 Feb; 58(3):437-41. PubMed ID: 9458086
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Peptide-based radiopharmaceuticals for targeted tumor therapy.
    Dong C; Liu Z; Wang F
    Curr Med Chem; 2014; 21(1):139-52. PubMed ID: 23992337
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Peptide receptor imaging: advances in the diagnosis of pulmonary diseases.
    Van de Wiele C; Signore A; Dierckx RA
    Am J Respir Med; 2002; 1(3):177-83. PubMed ID: 14720055
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals.
    Khan IU; Beck-Sickinger AG
    Anticancer Agents Med Chem; 2008 Feb; 8(2):186-99. PubMed ID: 18288921
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tetraamine-coupled peptides and resulting (99m)Tc-radioligands: an effective route for receptor-targeted diagnostic imaging of human tumors.
    Nock B; Maina T
    Curr Top Med Chem; 2012; 12(23):2655-67. PubMed ID: 23339761
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development and application of peptide-based radiopharmaceuticals.
    Dijkgraaf I; Boerman OC; Oyen WJ; Corstens FH; Gotthardt M
    Anticancer Agents Med Chem; 2007 Sep; 7(5):543-51. PubMed ID: 17896914
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Radiolabeled regulatory peptides for imaging and therapy.
    Nanda PK; Lane SR; Retzloff LB; Pandey US; Smith CJ
    Curr Opin Endocrinol Diabetes Obes; 2010 Feb; 17(1):69-76. PubMed ID: 19901831
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development of radiocontrast agents for vascular imaging: progress to date.
    Blankenberg FG; Mari C; Strauss HW
    Am J Cardiovasc Drugs; 2002; 2(6):357-65. PubMed ID: 14727951
    [TBL] [Abstract][Full Text] [Related]  

  • 72. From Bench to Bedside-The Bad Berka Experience With First-in-Human Studies.
    Zhang J; Singh A; Kulkarni HR; Schuchardt C; Müller D; Wester HJ; Maina T; Rösch F; van der Meulen NP; Müller C; Mäcke H; Baum RP
    Semin Nucl Med; 2019 Sep; 49(5):422-437. PubMed ID: 31470935
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.
    Tornesello AL; Buonaguro L; Tornesello ML; Buonaguro FM
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28767081
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnostic and therapeutic applications of radiolabeled somatostatin analogs: current status in an oncology center.
    Podoloff DA
    Curr Pharm Des; 2002; 8(20):1809-14. PubMed ID: 12171532
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bioconjugates of Chelators with Peptides and Proteins in Nuclear Medicine: Historical Importance, Current Innovations, and Future Challenges.
    Jackson JA; Hungnes IN; Ma MT; Rivas C
    Bioconjug Chem; 2020 Mar; 31(3):483-491. PubMed ID: 31990543
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Structural modifications of amino acid sequences of radiolabeled peptides for targeted tumor imaging.
    Maleki F; Farahani AM; Rezazedeh F; Sadeghzadeh N
    Bioorg Chem; 2020 Jun; 99():103802. PubMed ID: 32330735
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Radiolabeled Peptides and Antibodies in Medicine.
    Kręcisz P; Czarnecka K; Królicki L; Mikiciuk-Olasik E; Szymański P
    Bioconjug Chem; 2021 Jan; 32(1):25-42. PubMed ID: 33325685
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Application of radiolabeled peptides in tumor imaging and therapy.
    Mohtavinejad N; Shafiee Ardestani M; Khalaj A; Pormohammad A; Najafi R; Bitarafan-Rajabi A; Hajiramezanali M; Amanlou M
    Life Sci; 2020 Oct; 258():118206. PubMed ID: 32758623
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Targeted therapy in nuclear medicine--current status and future prospects.
    Oyen WJ; Bodei L; Giammarile F; Maecke HR; Tennvall J; Luster M; Brans B
    Ann Oncol; 2007 Nov; 18(11):1782-92. PubMed ID: 17434893
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Radiolabelled peptides--promises and pitfalls.
    Mather SJ
    Nucl Med Commun; 2000 Jun; 21(6):507-9. PubMed ID: 10894558
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.